Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa A Robb

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA|March 16, 2016
Biomarkers and Surrogate Endpoints: Developing Common Terminology and DefinitionsMelissa A Robb, Pamela M McInnes, Robert M Califf
Medical Care|October 11, 2012
Active surveillance of postmarket medical product safety in the Federal Partners' CollaborationMelissa A Robb, Judith A Racoosin, Chris Worrall, et al.
Nature Reviews. Drug Discovery|February 25, 2017
Accelerating development of scientific evidence for medical products within the existing US regulatory frameworkRachel E Sherman, Kathleen M Davies, Melissa A Robb, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot programSusan Forrow, Daniel M Campion, Lisa J Herrinton, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safetyMelissa A Robb, Judith A Racoosin, Rachel E Sherman, et al.
The New England Journal of Medicine|December 14, 2016
Real-World Evidence - What Is It and What Can It Tell Us?Rachel E Sherman, Steven A Anderson, Gerald J Dal Pan, et al.
The New England Journal of Medicine|December 16, 2016
Transforming Evidence Generation to Support Health and Health Care DecisionsRobert M Califf, Melissa A Robb, Andrew B Bindman, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA|March 16, 2016
Biomarkers and Surrogate Endpoints: Developing Common Terminology and DefinitionsMelissa A Robb, Pamela M McInnes, Robert M Califf
Medical Care|October 11, 2012
Active surveillance of postmarket medical product safety in the Federal Partners' CollaborationMelissa A Robb, Judith A Racoosin, Chris Worrall, et al.
Nature Reviews. Drug Discovery|February 25, 2017
Accelerating development of scientific evidence for medical products within the existing US regulatory frameworkRachel E Sherman, Kathleen M Davies, Melissa A Robb, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot programSusan Forrow, Daniel M Campion, Lisa J Herrinton, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safetyMelissa A Robb, Judith A Racoosin, Rachel E Sherman, et al.
The New England Journal of Medicine|December 14, 2016
Real-World Evidence - What Is It and What Can It Tell Us?Rachel E Sherman, Steven A Anderson, Gerald J Dal Pan, et al.
The New England Journal of Medicine|December 16, 2016
Transforming Evidence Generation to Support Health and Health Care DecisionsRobert M Califf, Melissa A Robb, Andrew B Bindman, et al.
Pageof 1